packageRaloxifene

raloxifene

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Raloxifene, a selective estrogen receptor modulator, is used to treat osteoporosis in postmenopausal women. It is authorised in the European Union and remains an approved medicine, though it carries a boxed warning.

Summary written by glm-5.3-flash from Wikidata Q425223 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:raloxifene
ATC codes:G03XC01
DrugBank:DB00481
PubChem CID:5035
ChEBI:8772
Wikidata:Q425223
formula:C28H27NO4S
molar mass:473.587 g/mol (PubChem CID 5035)
logP:6.1 (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown